Skip to content

Enovis ENOV Free cash flow

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Stryker logo
StrykerSYK
$415M+227%
ESAB logo
ESABESAB
$33.21M+18.1%
Vericel logo
VericelVCEL
$15.13M+299%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Calculated from Enovis’s reported figures.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's free cash flow?
Enovis (ENOV) reported free cash flow of -$28.85M in Q1 2026.
How has Enovis's free cash flow changed year-over-year?
Enovis's free cash flow increased by 35.7% year-over-year, from -$44.86M to -$28.85M.
What is the long-term trend for Enovis's free cash flow?
Over 2 years (2021 to 2023), Enovis's free cash flow has grown at a -77.5% compound annual growth rate (CAGR), from $251.86M to $12.77M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.